Glaucoma is frequently referred to as the silent thief of sight, because most of its types classically show no pain, no symptoms until perceptible vision loss occurs. A glaucoma is a group of connected eye disorders that occurs owing to damage to the optic nerve which transmits information from the eye to the brain. Most of the cases, linked with ocular hypertension, a condition when the pressure inside the eye is greater than normal pressure but sometimes it can occur when intraocular heaviness is normal. If it remains untreated, first it causes peripheral vision loss and progressively mat leads to permanent blindness.
Glaucoma
is the second leading cause of blindness around the world. A tonometer is utilized
to measure intraocular pressure (IOP) throughout routine eye checkups. Normally
IOP should be below 21 mmHg. Treatment of glaucoma entails surgery, laser
treatment, medication which is relying upon severity. Most eye drops are utilized
for lowering IOP that is considered as the first control for glaucoma. Most individuals
become careless about strict use of eye drop thus, not complying with
prescribed medication is a foremost reason behind blindness.
According
to the report analysis, ‘Global Glaucoma Treatment Market Status (2015-2019)
and Forecast (2020-2024) by Region, Product Type & End-Use’ states
that Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch &
Lomb Incorporated, Teva Pharmaceuticals, Pfizer, Santen, Aerie Pharmaceuticals,
Inotek Pharmaceuticals and many more are the key companies which presently
working in the global Glaucoma treatment market more efficiently for ruling
around the globe, registering the great value of market share, keep maintaining
the governing position, generating the highest percentage of revenue and
obtaining the competitive edge by analysing the strategies and policies of
government as well as contenders, increasing the features and benefits of
glaucoma treatment, implementing the policies of profit making and strategies
of expansion, spreading the awareness connected to the applications and
advantages of glaucoma treatment, improving the qualitative and quantitative
measures of such, delivering the better customer satisfaction, decreasing the
associated prices of such, and establishing the several research and
development programs.
Also,
technological innovations in treatment as eye drop is the primary control sage
for glaucoma, and several pharmaceutical and biotechnological companies are contributing
in new product development for Glaucoma is another cause behind the growth in
the Glaucoma Treatment Market. Therefore, it is predicted that during the near
future the market of glaucoma treatment will augment more progressively over
the review period around the globe.
For More Information, refer to
below link:-
Global
Glaucoma Treatment Market
Contact Us: -
Ken Research
Ankur Gupta, Head Marketing & Communications
support@kenresearch.com
+91-9015378249
